stock
LNAI · Lunai Bioworks Inc.
No insider buys or sales filed in 90 days; last 8-K filed Nov 12: executive or director change.
Follow LNAI freePrice
Loading the LNAI chart…
Chart by TradingView
The business
What the company does and what it reports, from its SEC filings.
What it is
As of June 30, 2026, Lunai Bioworks Inc. operated principally through two operating subsidiaries, Renovaro Biosciences and BioSymetrics; a third wholly owned subsidiary, Lunai Bioworks IP, Inc., holds the intellectual property acquired in the May 2026 Neurobridge acquisition, including the N2B intranasal drug delivery platform. BioSymetrics refers to BioSymetrics Inc. and its wholly owned subsidiary BioSymetrics Corp., which were acquired on April 8, 2025. During the quarter ended September 30, 2025, GEDi Cube B.V. ("GEDi Cube"), acquired on February 13, 2024, filed for bankruptcy and ceased operations. Following GEDi Cube's bankruptcy and subsequent deconsolidation, the Company continued pursuing its AI-driven precision medicine and biomarker discovery strategy through BioSymetrics, which had been acquired prior to the bankruptcy.
From the 10-K for the fiscal year ended Jun 30, 2026, filed Oct 13, 2026.
Read the 10-K on SEC- Sector
- Life Sciences (SEC office)
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Employees
- 12
- Headquarters
- Suite 906 Los Angeles, CA
- Incorporated in
- DE
- Fiscal year ends
- June
- Exchange
- Nasdaq
- Fractional shares
- No
- Listed options
- Yes
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Formerly
- RENOVARO INC. (until 2025); RENOVARO BIOSCIENCES INC. (until 2024); Enochian Biosciences Inc (until 2023)
- Shares outstanding
- 5,034,452 as of Oct 13, 2026 (XBRL frame CY2026Q3I)
- Filer (SEC EDGAR)
- EDGAR filing index
Key stats
Valuation and the ratios that use the live price are free with an account.
Start free to see thisDeep value
- NCAV
- -$16.93M
- NCAV per share
- -$3.36
- NNWC
- -$17.25M
- NNWC per share
- -$3.43
Expectations
- Free cash flow, FY2026
- -$5.29M
- Free cash growth, last 5 years
- —
- Revenue growth, last 5 years
- —
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- —
- ROA
- -35.8%
Health
- Current ratio
- 0.1x
- Debt/equity
- —
Trailing twelve months to Jun 30, 2026; balance sheet at Jun 30, 2026.
Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| Jun 30, 2026 | — | — | -$2.09M | -$2.01M | Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| Mar 31, 2026 | $20,942 | $20,942 | -$1.48M | -$2.57M | |
| Dec 31, 2025 | — | — | -$1.82M | -$1.80M | Assembled from more than one filing; the filing above is only the newest of them. |
| Sep 30, 2025 | — | — | -$3.31M | $2.82M | Assembled from more than one filing; the filing above is only the newest of them. |
| Jun 30, 2025 | — | — | -$126.92M | -$126.73M | Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| Mar 31, 2025 | — | — | -$4.16M | $189,176 | |
| Dec 31, 2024 | — | — | -$4.55M | -$7.25M | Assembled from more than one filing; the filing above is only the newest of them. |
| Sep 30, 2024 | — | — | -$53.34M | -$44.21M | Assembled from more than one filing; the filing above is only the newest of them. |
- Cash
- $1.71M
- Debt
- —
- Net cash
- —
- Current assets
- $2.04M
- Current liabilities
- $18.91M
- Working capital
- -$16.87M
- Total liabilities
- $18.97M
- Assets
- $9.94M
- Equity
- -$9.02M
Balance as of Jun 30, 2026.
SEC data as of Nov 17, 2026
Earnings moves
No results filings
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $51,992 | -$8.70M | -$3.56M | -$5.29M |
| Jun 30, 2025 | — | -$188.97M | -$178.01M | — |
| Jun 30, 2024 | — | -$81.64M | -$88.43M | -$11.04M |
| Jun 30, 2023 | — | -$38.56M | -$39.68M | -$11.80M |
| Jun 30, 2022 | — | -$116.08M | -$113.43M | -$15.74M |
| Jun 30, 2021 | — | -$23.40M | -$26.72M | -$20.66M |
| Jun 30, 2020 | — | -$11.92M | -$11.42M | -$10.64M |
| Jun 30, 2019 | — | -$10.99M | -$18.02M | -$9.22M |
| Jun 30, 2018 | — | -$5.33M | -$6.31M | -$4.37M |
| Jun 30, 2017 | — | -$2.40M | -$2.14M | — |
What it filed
Material events and 5% ownership filings from the last year.
Company filings
1 offering filing in 12 months
events
5% owners ()
William Anderson Wittekind
Stake update
Hansen Hans Christian
Passive stake
William Anderson Wittekind
Stake update
William Anderson Wittekind
Stake update
Owners and trading
Insider, politician and fund moves, short interest, and the volume traded off the exchange.
Insiders, politicians and funds
Insider trades, last 90 days
No insider buys or sales filed in the last 90 days.
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
Short interest
Hard to borrow: Alpaca will not lend it for shorting
Shares short
19,381
Of shares outstanding
0.4%
Days to cover
1.0
Change since last report
-83.4%
Settlement date Oct 30, 2026
Off-exchange short volume, 20 days
42.9%
Through Oct 29, 2026
Of the volume reported to FINRA's off-exchange facilities, market makers' hedging included. It is not short interest.
Short interest and short volume: FINRA
Off-exchange and dark pools
About 13.8% of shares traded off the exchanges
Period ending Oct 30, 2026, FINRA
Week of Oct 12, 2026, published by FINRA 2 to 4 weeks later
- Dark pools (ATS)10.5%
- Wholesalers and other dealers89.5%
Venues, week of Oct 12, 2026
Top dark pools
- UBSA UBS ATS3,917
- EBXL LEVEL ATS3,634
- INCR INTELLIGENT CROSS LLC1,665
- CGXS ONECHRONOS1,547
- SGMT SIGMA X21,322
This shows where shares traded, not who bought or sold. Most off-exchange volume is retail orders filled by wholesalers.
Source: FINRA
Members see
- Signals: which strategies fired on LNAI, and the evidence behind each
- Options positioning: the levels dealers are hedged around
- Technicals: trend and momentum readings
- Earnings moves: how the price moved after each report
- News: stories counted once across outlets
nakagai
Signals on LNAI come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Follow LNAI free
Comments · 0
No comments yet.